Avandia Safety Review Planned By U. Miami-Humana Data Mining Venture
Executive Summary
A safety analysis of GlaxoSmithKline's Avandia is among the first evaluations planned by a pharmacovigilance initiative announced by the University of Miami and Humana Aug. 22